The National Breast Cancer Coalition (NBCC) applauds today’s Supreme Court decision in California v. Texas which preserves the Affordable Care […]
“Changes to FDA warnings and labeling should be grounded in rigorous, contemporary evidence—not post-hoc or subgroup re-analyses of older trials. ”
“As a breast cancer survivor, [Visco] turned pain into purpose, changed the landscape of breast cancer advocacy, and has become a powerful symbol of hope for the nation.”
Nicole Levins, communications director
nlevins@stopbreastcancer.org
The National Breast Cancer Coalition (NBCC) applauds today’s Supreme Court decision in California v. Texas which preserves the Affordable Care […]
Urge Your Members of Congress to Cosponsor S. 1312/H.R. 3183 by Father’s Day Let’s tell Congress this is urgent! We […]
Project LEAD Institute 2022 NBCC is thrilled to announce that the Project LEAD Institute will resume in the summer of […]
2021 Summit Virtual Lobby Day Recap After four days of summit programming and lobby day prep, on Tuesday, May 18, […]
ODAC Votes. Win for Industry, Not for Patients. On April 27, 2021, at the Oncologic Drug Advisory Committee (ODAC) […]
We all want new treatments to “work” for breast cancer patients. For the National Breast Cancer Coalition (NBCC), that means […]
